Established in 2002, Wong Beh & Toh has built a strong reputation among its peers for advising on equity capital markets transactions. The firm is particularly active in initial public offerings and secondary listings on major Malaysian exchanges. In addition to its equity capital markets work, the firm also provides clients with guidance on general corporate and mergers and acquisitions matters, encompassing both inbound and outbound investments. The key partners leading the firm’s practice are Wong Tat Chung, Patricia Toh and Cynthia Toh.
Client feedback
“Ability to provide a solution that suits our requirement in fast mode.” – Corporate and M&A
Lin Lin Yeap
“Wong Beh & Toh, especially the lawyer in-charge, Lin Lin Yeap, has provided strategic foresight and advice in helping us to navigate complex regulatory frameworks and corporate structures. We are very happy with the firm's unwavering professionalism and effective solutions along our listing journey. The lawyer's diligence, attention to details, integrity and commitment are what we treasure most!”
“Lin Lin is a highly professional and approachable lawyer who combined deep legal knowledge with a strong commercial instinct. She manages to communicate complex legal issues in clear, accessible terms, and consistently delivers practical, business-minded solutions.”
Work highlights
Advising Pekat Teknologi, a wholly owned subsidiary of Pekat Group, on its RM96 million acquisition of a 60% equity stake in Apex Power Industry, the holding company of EPE Switchgear.
Key clients
3Ren, Northeast Group
Work highlights
Advised Nationgate Holdings on Malaysia's first accelerated transfer listing from ACE Market to Main Market of Bursa Malaysia Securities under the revised Chapter 8 of the Equity Guidelines. The landmark transaction, completed in May 2024 for the $1.3 billion market cap company, demonstrated the efficiency of the new framework by securing approval within two weeks of submission, establishing a precedent for streamlined market transfers that meet the required RM1 billion ($237 million) market capitalisation thresholds.
Advising UMediC Group on its transfer listing from Bursa Malaysia's ACE Market to the Main Market, marking a significant milestone in the company's growth trajectory. The $45 million market cap healthcare company's transition required comprehensive legal due diligence to ensure compliance with dual regulatory frameworks – industry-specific healthcare regulations and Main Market listing requirements.
